Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Chris Sale

Chris Sale To Be Activated On Saturday

By | at

Chris Sale will be activated and start for the Red Sox this Saturday, according to Alex Speier of the Boston Globe. This will mark the end of a long absence for Sale, who has been out of action for two whole years now.

In August of 2019, Sale began having elbow problems that forced him to miss the remainder of the season. Although Tommy John surgery was not recommended at the time, it would be eventually, and Sale underwent the procedure in March of 2020.

If he can quickly return to his previous form, or anything close to it, it will be a huge upgrade for a Red Sox team that has recently slid in the standings, surrendering the top spot in the AL East to the Rays. The lefty has been one of the best pitchers in baseball over the past decade. Since his 2010 debut, he has thrown 1629 2/3 innings, with a 3.03 ERA and excellent strikeout and walk rates of 30.7% and 5.7%.

In other Red Sox news, Alex Verdugo has gone on the paternity list and will be away from the team for a few days, per Bill Koch of the Providence Journal. MassLive’s Chris Cotillo adds that Connor Wong has been optioned, while Jarren Duran and JD Martinez have been activated from the COVID-IL. Both Duran and Martinez went on the IL in recent days because they weren’t feeling well. COVID testing must have come back negative, because a positive test would have resulted in a 10-day quarantine. Wong was only just recalled to help cover for their absence but didn’t get into any game action.

Red Sox Notes: Bloom, Scherzer, Sale, Fabian

By | at

Acquiring one of the game’s better power hitters in Kyle Schwarber doesn’t exactly make for a quiet deadline season, though compared to what other AL contenders did in July, the Red Sox were comparatively modest in picking up Schwarber and relievers Hansel Robles and Austin Davis.  Chief baseball officer Chaim Bloom told MLB.com’s Ian Browne and other reporters that the Sox looked into several trade possibilities, but teams put a very high price tag on pitchers in particular, leaving Bloom’s front office unwilling to sacrifice too much of the future for a short-term gain.

“There were a lot of things that were put to us where we just felt we’re not doing our jobs and ultimately we’re going to let our fans down, whether it be tomorrow or whether it be next year or the year after or all of the above if we did some of things we could’ve done to make more of a splash,” Bloom said.  The $210MM luxury tax threshold “was never a hard line” that prevented the Sox from making a trade, and Bloom said the team indeed considered some moves that would put them in excess of the $210MM figure.  However, “we just didn’t feel like it was worth the cost in talent, let alone the additional effects of going over the line.”

Bloom also denied a report that ownership put pressure on the front office to land Max Scherzer.  The Sox were known to have interest in the former Nationals ace, and Scherzer was reportedly open to the idea of waiving his no-trade protection to come to Boston, before he eventually agreed to be dealt to the Dodgers.

More from Fenway Park…

  • Chris Sale threw 81 pitches over five innings in a Triple-A rehab start yesterday, the longest stint to date of his four minor league rehab outings.  Working a more standard game appeared to Sale, who told The Boston Globe’s Alex Speier and other reporters that “I’m starting to get into more of a normal routine and more of fighting the same fight everyone else is fighting, instead of having an injured elbow, fighting back, rehabbing.  I don’t feel that way.  That’s big.”  Sale mostly threw his fastball in the 91-93mph range but occasionally reared back to touch the 96mph mark, while striking out seven and allowing one run (on five hits and a walk) over his five innings.  The left-hander is scheduled for one more Triple-A rehab start this week, and he could then potentially make his long-awaited return to the Red Sox rotation.
  • Second-round pick Jud Fabian won’t be signing with the Red Sox, as a tweet from his personal account more or less (with an assist from Eminem) officially stated he will return to the University of Florida for his senior year.  A $1,856,700 slot price is attached to the 40th overall selection, and rumors have circulated that the two sides were a good distance apart in negotiations — The Athletic’s Peter Gammons reported that Fabian could have landed $3MM from two teams that picked later than the Sox in the second round.  Due to remaining pool space, MLB Pipeline’s Jim Callis writes that the Sox couldn’t give Fabian more than a $2,100,680 bonus without having to surrender a future first-round pick as punishment for exceeding their pool spending by more than five percent.  The Red Sox will receive the 41st overall selection in next year’s draft as compensation for not signing Fabian.

Chris Sale To Begin Rehab Assignment; Red Sox To Recall Tanner Houck

By | at

3:25PM: Sale threw three innings of work rather than his scheduled two in his first rehab outing today, Alex Speier of The Boston Globe reports.  The left-hander allowed three singles in his three shutout frames, and threw his fastball in the 94-95mph range, reaching as high as 97mph.  As for Houck, manager Alex Cora told Speier and other reporters that Houck will probably start against the Blue Jays on Wednesday, and be used in the bullpen for Boston’s current series against the Yankees.

11:37AM: Chris Sale is going to begin a rehab assignment today, according to Jen McCaffrey of The Athletic. Additionally, the Red Sox are planning on recalling Tanner Houck today, according to Dan Roche of WBZ.

As noted by Pete Abraham of the Boston Globe, this would be Sale’s first game since August 13th, 2019. Shortly after that, he was shut down with elbow inflammation but was not recommended for Tommy John surgery. Sale tried to come back for the 2020 season but eventually did require Tommy John and underwent the procedure in March of 2020, missing the entirety of that season.

Without Sale, the Red Sox floundered and wound up last in the AL East, finishing the shortened season with a record of 24-36. However, 2021 has been a complete reversal so far, as the club finds itself atop the division with a record of 55-36. Despite their strong placement in the standings, the rotation has not been a strong suit for them. The starters as a whole have produced an ERA of 4.47, 21st-best in the majors, although advanced metrics are a bit more charitable, with a FIP of 3.86, xFIP of 4.11 and a SIERA of 4.20. Concerns over the rotation have also become heightened lately. Garrett Richards has put up an ERA of 6.45 and Eduardo Rodriguez one of 5.35 since the start of June. Martin Perez and Nick Pivetta have not been much better, at 4.76 and 4.85 during that same timeframe, respectively. Nathan Eovaldi has been excellent but always comes with injury concerns. He’s he hasn’t surpassed 125 innings in a season since 2015 and has already tallied 103 1/3 this year.

Sale has been one of the best pitchers in baseball during his career and, if healthy, he would be a gamechanger for any rotation. From 2012 to 2019, Sale hurled 1535 1/3 innings with an ERA of 3.05, a strikeout rate of 30.8% and walk rate of 5.5%, which produced 42.8 fWAR and helped the Red Sox win the 2018 World Series in the process.

As the trade deadline approaches, the health and performance of Sale could impact the urgency with which Boston pursues rotation upgrades. The club has stayed under the luxury tax line so far, but just barely. (According to Roster Resource, their luxury tax hit is $208MM, just below the first threshold of $210MM.) That doesn’t leave a lot of wiggle room, if they insist on limboing under that line. But a healthy Sale would be a bigger upgrade than any trade acquisition they could hope to land in a trade.

In the meantime, the pitching staff is hoping for a boost from Houck as they begin an important series against the Yankees. Houck has put up a 3.07 ERA with 19 Ks and 3 BBs in 14 2/3 innings in Triple-A since returning from a flexor tendon strain.

East Notes: Turner, Familia, Nimmo, Sale, Moreno

By | at

It was a banner day for Trea Turner, as the Nationals shortstop celebrated his 28th birthday and tied a Major League record with his third career cycle.  Turner joins Adrian Beltre, Babe Herman, Bob Meusel, and Long John Reilly as the only players since 1890 with three cycles on their resume, putting Turner in good position to claim sole possession of the record before his career is over.

Unfortunately, the achievement wasn’t without some pain for Turner, as he jammed his left middle finger while sliding into third base for the triple that completed the cycle.  Turner told reporters (including Mark Zuckerman of MASNsports.com) that his finger was “pretty sore,” and manager Davey Martinez said Turner is day-to-day for the time being.  Turner’s big day (which also included two stolen bases) only continues what has been a big season for the shortstop, who is now hitting .318/.367/.513 with 14 homers, 18 stolen bases, and an even 50 runs and 100 hits over 341 plate appearances.

Some more injury news from around the NL and AL East divisions…

  • Jeurys Familia is expected to be activated off the 10-day injured list this weekend, Mets manager Luis Rojas told reporters (including Mike Puma of the New York Post).  A right hip impingement sidelined Familia on June 21, so he’ll miss only slightly more than the 10-day minimum.  Despite an ungainly 14.3% walk rate, Familia has a solid 3.63 ERA/4.31 SIERA over 22 1/3 IP, with a 58.5% grounder rate and a lot of soft contact helping offset his lack of control.
  • Brandon Nimmo could also potentially be back on the Mets roster this weekend.  Nimmo hasn’t played since May 2 due to what was initially called a left index finger contusion, then re-diagnosed as a potential nerve problem, and then as a small ligament tear.  This confusion led to a couple of stops and starts in Nimmo’s rehab, and an initial thought that he would be activated off the IL yesterday was held off since the team wanted him to get a bit more prep work in the minors.  Given all the setbacks, it probably shouldn’t be considered a sure deal for Nimmo until he is actually back at Citi Field, but things look promising for the outfielder.
  • Chris Sale threw live batting practice today at Fenway Park, tossing two simulated innings and reaching the 94-95mph threshold with his fastball, Red Sox manager Alex Cora told The Boston Globe’s Julian McWilliams and other reporters.  Sale is slated for another live BP session at the team’s Spring Training facility this weekend, and a rehab assignment could be the next step for the left-hander.  Sale underwent Tommy John surgery in March 2020 and has been projected to return by late July or early August, so he certainly seems to be on track with that timetable.  The Red Sox are leading the AL East despite some struggles within the rotation, and those issues could be greatly mitigated by a Sale who is healthy and anywhere close to his past superstar form.
  • The Blue Jays’ injury woes have extended to the minors, as GM Ross Atkins said that star catching prospect Gabriel Moreno suffered a “minor fracture” of his thumb after being hit by a pitch.  Atkins told Sportsnet’s Ben Nicholson-Smith and other reporters that Moreno will “most likely” miss several weeks, and surgery hasn’t been ruled out.  Moreno has a whopping .373/.441/.651 slash line and eight homers in 145 PA at Double-A New Hampshire this season, and Baseball America ranks the catcher 32nd on their top-100 prospect list.  While this injury certainly hampers Moreno’s trade value, his development had seemingly made him more of a cornerstone piece for the Jays than a potential trade chip as Toronto approaches the deadline.  Any of Danny Jansen, Alejandro Kirk, Reese McGuire, or Riley Adams could be more likely than Moreno to be dealt as the Jays look for upgrades on the trade market.

Health Notes: Sale, Middleton, Odor, Ona, Graterol

By | at

Red Sox ace Chris Sale worked off a mound today for the first time in his recovery from March 2020 Tommy John surgery, Jen McCaffrey of the Athletic was among those to relay (Twitter link). There’s still no timetable for Sale’s potential return to game action, although getting on the mound obviously represents a notable step forward. At 18-13, the Red Sox are off to a strong start and could be a legitimate contender in a tough AL East. Boston’s rotation looks to be the weak point on the roster, but it’s held up fairly well so far. Sox starters have a middle-of-the-pack 4.02 ERA/4.00 SIERA over the season’s first month-plus.

Other health situations around the league:

  • This morning, the Mariners announced they’ve placed reliever Keynan Middleton on the 10-day injured list with a right biceps strain. Fellow righty Wyatt Mills was recalled in his place. Middleton, 27, has tossed 11 2/3 innings of five-run ball in the early going, striking out nine against six walks. Middleton, who underwent a Tommy John surgery in May 2018, spent the 2017-20 seasons with the division-rival Angels.
  • The Yankees placed infielder Rougned Odor on the 10-day injured list this afternoon. He’s dealing with a left knee sprain. Right-hander Albert Abreu was recalled to take his place on the active roster. Odor, acquired from the Rangers at the beginning of the regular season, hasn’t offered a whole lot offensively in the early going. He’s hitting just .164/.271/.361 over his first 70 plate appearances with New York. To his credit, Odor has massively improved upon his strikeout and walk rates from recent seasons though.
  • Padres outfielder Jorge Oña underwent arthroscopic surgery on his right elbow yesterday, Dennis Lin of the Athletic was among those to pass along (Twitter link). He’s expected to be out of action for six to eight weeks. Oña, 24, made a very brief MLB debut last season, tallying 15 plate appearances over five games. Other than that limited major league time, Oña only has 103 trips to the plate above the low minors (in Double-A in 2019), so he likely would’ve started the year at Triple-A El Paso even if he’d been healthy.
  • Dodgers reliever Brusdar Graterol, placed on the injured list last week because of forearm tightness, was known to be headed for an MRI. Fortunately, testing showed no structural damage, manager Dave Roberts told reporters (including Bill Plunkett of the Orange County Register). That’s especially welcome news since the flamethrowing Graterol underwent a Tommy John procedure back in 2016. There’s still no indication when he might return to game action.

East Notes: Braves, Smyly, Sale, Orioles, Kjerstad

By and | at

The Braves are planning to activate Drew Smyly from the injured list to start Saturday’s game against the Diamondbacks, David O’Brien of the Athletic was among those to relay (Twitter link). The left-hander was placed on the IL last week with forearm inflammation, but he’ll return after missing just one start. Smyly has allowed nine runs (seven earned) over his first eleven innings for Atlanta, but he’s struck out eleven with just a single walk to this point.

Elsewhere in Atlanta and the game’s East divisions:

  • In other Braves’ pitching news (also via O’Brien), reliever Chris Martin has started throwing as he begins his ramp-up. The right-hander hit the injured list in early April with shoulder inflammation but O’Brien says he could return by the end of Atlanta’s upcoming homestand, which runs through the 29th. Max Fried, who went on the shelf last week after straining his hamstring, seems to be further behind. He has not yet begun throwing and there’s no timetable for his return, per O’Brien. Like Martin, Mike Soroka is dealing with shoulder inflammation; the 23-year-old is expected to begin a throwing program sometime soon, but manager Brian Snitker suggested he’s still far away from any potential return to game action (via Gabe Burns of the Atlanta Journal-Constitution).
  • Red Sox ace Chris Sale is progressing in his recovery from March 2020 Tommy John surgery, Chris Cotillo of MassLive.com relays. Sale isn’t throwing off a mound yet, but manager Alex Cora said he’s “getting closer.” The left-hander will report to the team’s complex in Florida on Sunday to continue his rehab. Sale “feels great,” according to Cora, though the Red Sox still aren’t ready to offer a timetable on a potential 2021 return. Even without Sale, the Red Sox have surprisingly begun the season with an American League-best 12-6 record. Nathan Eovaldi and Eduardo Rodríguez have been the top performers in Boston’s rotation this year in Sale’s absence.
  • Orioles outfield prospect Heston Kjerstad has been medically cleared to report to the team’s alternate training site, per Jim Callis of MLB.com. Kjerstad, the No. 2 pick in last year’s draft, has been away from the club while recovering from myocarditis. The 22-year-old will need “a months-long buildup” before he’s ready for game action, Callis tweets.

Red Sox Claim John Schreiber, Place Chris Sale On 60-Day IL

By | at

The Red Sox announced this afternoon that they’ve claimed righty John Schreiber off waivers from the Tigers and placed left-hander Chris Sale on the 60-day injured list to open a 40-man roster spot. The Sale move shouldn’t come as a shock, given that he underwent Tommy John surgery on March 30 last year. It was reported last month that his rehab was expected to come near the back end of the typical 12-15 month recovery time. He’ll likely be an option for the Sox sometime early this summer.

Schreiber, 27 next month, has pitched 28 2/3 innings with Detroit over the past two seasons but has not fared well, logging a 6.28 ERA in that time. Other metrics are more bullish on the former 15th-round pick, however, thanks largely to an above-average 25.6 percent strikeout rate and a very manageable 6.2 percent walk rate. The sidearm-slinging Schreiber has a career 1.99 ERA in four minor league seasons, including a 2.28 mark in 59 1/3 innings at Triple-A.

Schreiber doesn’t throw particularly hard, as is common with sidearmers, but he’s been a thorn in the side of hitters throughout his minor league tenure — righties in particular. Right-handed opponents posted a laughable .192/.270/.311 slash against him in 2019. Beyond that, Schreiber has multiple minor league option years remaining, giving the Red Sox both depth and flexibility with their bullpen should they choose to keep him on the 40-man roster.

Red Sox Notes: Pedroia, Benintendi, Sale, Lester

By | at

“A resolution” between Dustin Pedroia and the Red Sox could come at some point this month, The Boston Globe’s Pete Abraham reports (Twitter link).  Knee injuries limited Pedroia to just nine games in 2018-19, and he didn’t play at all during the 2020 season, with Abraham adding that Pedroia isn’t intending to make one final comeback attempt.  2021 marks the final season of the eight-year, $110MM extension Pedroia signed in July 2013, and the second baseman is owed $12MM for the coming season.

There has been an expectation that Pedroia could be cut loose in one fashion or another once the Sox were in need of a 40-man roster spot, as their 40-man is currently full.  Some type of buyout rather than an outright release is probably the likelier route, since “given Dustin’s status, [the Sox will] want to do this correctly,” Abraham notes.  One of the key figures in this era of Red Sox baseball, Pedroia hit .299/.365/.439 over 6777 career plate appearances (all in a Sox uniform), with a resume that includes the 2008 AL MVP Award, four All-Star appearances, and World Series rings from Boston’s 2007 and 2013 championship seasons.

Some more from Fenway Park…

  • The Red Sox have asked at least one team for “a younger corner outfielder along with a minor-league pitcher not necessarily on the 40-man roster” as the trade return for Andrew Benintendi, WEEI.com’s Rob Bradford writes.  While Benintendi has drawn interest from several teams, the Phillies and Reds haven’t been involved in talks.  (The Rangers are also not in the mix, as Bradford originally reported last week.)  Former Red Sox president of baseball operations Dave Dombrowski is now running the Phils’ front office and the Reds have explored a Benintendi trade in the past, so there was speculation that those two clubs could be looking into acquiring Benintendi this time around.
  • Chris Sale’s return from Tommy John surgery is likely to come on the higher end of the usual 12-15 month recovery timeline, as ESPN.com’s Buster Olney writes that the Sox are “expected to be deliberate” in bringing the southpaw back to action.  Sale underwent his TJ procedure at the end of last March, putting him on track to return in late June or early July.  (Assuming the 2021 schedule goes as planned, it is easy to see a scenario where Sale doesn’t pitch until after the July 12-14 All-Star break.)  Since Sale is under contract through at least the 2024 season, the club is “apt to take a conservative approach” to ensure that Sale is fully recovered and ready for 2022 and beyond, rather than rushing him in any way this season.
  • The Red Sox hadn’t been in touch with Jon Lester as of December 9, Rob Bradford reported last month, and Bradford tweeted yesterday that there hadn’t been any new contact between the two sides prior to Lester’s new deal with the Nationals.  While Boston has been looking at a wide range of starting pitching options this offseason, it seems like a reunion with Lester was simply not on the club’s radar.

Pitching Notes: Soria, Zimmermann, Sale, Price, LeBlanc

By | at

It seems veteran hurler Joakim Soria is drawing quite a lot of interest from the American League West. MLB.com’s Jon Morosi tweets that the Angels, Astros, Athletics, and Rangers are all pursuing Soria to some degree. Of course, most teams could stand to add an experienced late-inning reliever coming off of a quality season, so it stands to reason that just about every club in a competitive division would give a look. Soria, 36, registered a strong 2.82 ERA last year in Oakland, though that’s hardly a determinative measure on its own for a reliever in a shortened season. The well-traveled hurler managed only a 9.6% swinging-strike rate, his lowest in quite some time, and suddenly shifted to being a heavy flyball pitcher (though he wasn’t punished with many home runs in the short sample).

More from the pitching market:

  • After wrapping up a greatly disappointing tenure with the Tigers, Jordan Zimmermann is taking quite a different free agent journey than his first one. It’s fair to wonder whether he’d consider retiring, but the 34-year-old tells MLB.com’s Jason Beck (Twitter link) that he’s instead preparing for another campaign. Zimmermann is sure to draw interest, but not on a guaranteed big-league pact. He has largely been ineffective since coming to Detroit five seasons back and is now also recovering from a forearm injury.
  • The Red Sox could soon get a good sense of the return timeline for star lefty Chris Sale. Per MassLive’s Chris Cotillo (via Twitter), Sale is expected to throw from a mound at some point in the next two weeks or so — if all goes as planned. It’s promising that he’s already nearing that milestone, having undergone his Tommy John procedure at the end of March of 2020. It is hard to imagine that Sale will be ready for the start of the season, but perhaps he could resume competitive pitching relatively early in the 2021 campaign.
  • Also on his way back is Sale’s former teammate David Price. He posted a video on Twitter showing that he’s hard at work preparing for the upcoming season. The Dodgers will surely be interested to see how the ball is coming out of the once-great lefty’s hand after a long respite. Price, who was acquired in a blockbuster nearly one year ago, has yet to take the ball with his new team. He opted out of the 2020 season.
  • Teams looking for a spot starter and long reliever will soon have another option to consider. Southpaw Wade LeBlanc is still plugging away despite suffering a tough elbow injury last year. Per MLB.com’s Jon Morosi (Twitter link), LeBlanc is in good enough form that he’s now preparing for a showcase. LeBlanc posted a resurgent 2018 season but has struggled more recently, so he’s sure to land a non-guaranteed deal when he does sign.

Latest On Chris Sale, Eduardo Rodriguez

By | at

Normally contenders, the Red Sox finished with one of the majors’ worst records in 2020, winning just 24 of 60 games. One obvious reason? They received zero contributions from their two best starters, left-handers Chris Sale and Eduardo Rodriguez, who missed the season with health problems.

While it would be nice for the Red Sox to get full years from both Sale and Rodriguez in 2021, that doesn’t appear likely. Regarding Sale, chief baseball officer Chaim Bloom revealed Thursday (via Jason Mastrodonato of the Boston Herald) that the ace won’t be available when next season begins.

“When he comes back, that’s upside,” Bloom said. “Because we know that’s not going to be at the beginning of the season.”

Sale underwent Tommy John surgery in March, and that typically requires a 12- to 15-month recovery period. With that in mind, it’s not surprising that Boston will miss Sale for some portion of time next year. But it’s still less than ideal for a team that signed Sale to a five-year, $145MM extension that just kicked in this past season.

The news is much better for Rodriguez, who on Thursday told MLB Network Radio, “I will be 100 percent ready for next season.” Rodriguez had a career campaign in 2019, but COVID-19 and myocarditis shelved him this year. He was just cleared to begin walking again in late September, so it’s remarkable that Rodriguez is on track to be in the Red Sox’s season-opening rotation in a few months.

Besides Rodriguez and Nathan Eovaldi, the Red Sox might not be sure who will be in their starting staff when next year commences. Their rotation stumbled to a bottom-of-the-barrel 5.34 ERA/5.50 FIP in 2020, though Tanner Houck and Nick Pivetta showed quite a bit of promise over a combined five starts and could earn spots. Otherwise, Boston may try to pick up at least one veteran in free agency to fill out the group.

[RELATED: Red Sox Offseason Outlook]

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top